{"id":"W2569188319","doi":"10.1016/j.jtho.2016.11.363","title":"OA23.05 First-Line Afatinib versus Gefitinib in EGFRm+ Advanced NSCLC: Updated Overall Survival Analysis of LUX-Lung 7","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; Ottawa Hospital; McGill University","funders":"","keywords":"Afatinib; Medicine; Gefitinib; Internal medicine; Clinical endpoint; Rash; Lung cancer; Oncology; Gastroenterology; Randomized controlled trial; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002225932,0.001056573,0.002821903,0.0008578766,0.0002714228,0.001812042,0.001214961,0.0008054697,0.002439191],"category_scores_gemma":[0.002129898,0.0003207768,0.006159393,0.00118478,0.000363244,0.001701305,0.0006751337,0.00182005,0.0003945777],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001578378,"about_ca_system_score_gemma":0.0009137047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003818557,"about_ca_topic_score_gemma":0.01339502,"domain_scores_codex":[0.9989765,0.000256602,0.0001208881,0.0002709193,0.0001644083,0.0002107595],"domain_scores_gemma":[0.998626,0.0003586056,0.0004809581,0.0001299285,0.0001708012,0.0002336934],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1810487,0.001149345,0.4190314,0.004085903,0.06811177,0.0004804051,0.0002150866,0.008927502,0.004140701,0.0009451373,0.01297812,0.2988859],"study_design_scores_gemma":[0.02618689,0.02431678,0.8287162,0.0006965882,0.08469535,0.001756366,0.0004480999,0.01062421,0.001978357,0.002085872,0.01826687,0.0002282635],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.943145,0.04444679,0.000693814,0.000826893,0.0002997531,0.0001128854,0.006999589,0.00009886693,0.003376457],"genre_scores_gemma":[0.9818724,0.006147559,0.0005051488,0.0005317202,0.0002447181,0.00007265366,0.00924279,0.00003544539,0.001347581],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003818557,"threshold_uncertainty_score":0.01177204,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03947480103602784,"score_gpt":0.4819339292348827,"score_spread":0.4424591281988548,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}